Sale!

CLN6 Gene Ceroid lipofuscinosis neuronal type 6 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLN6 gene ceroid lipofuscinosis neuronal type 6 genetic test is a specialized diagnostic tool used to identify mutations in the CLN6 gene, which are linked to a rare, inherited neurodegenerative disorder known as neuronal ceroid lipofuscinosis type 6 (NCL6). This condition is part of a group of disorders that lead to progressive deterioration of the nervous system, manifesting in symptoms such as vision loss, motor function decline, and cognitive impairment. Early and accurate diagnosis through genetic testing can be crucial for management and treatment planning.

Performed at DNA Labs UAE, the test involves analyzing the patient’s DNA to detect mutations in the CLN6 gene that are responsible for the condition. This state-of-the-art facility ensures accurate and reliable results, utilizing the latest in genetic testing technology. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed report provided to patients or their caregivers.

By opting for this test, individuals suspected of having NCL6 can gain valuable insights into their condition, enabling healthcare providers to devise a tailored approach to treatment and management, potentially improving quality of life and outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLN6 Gene Ceroid lipofuscinosis neuronal type 6 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for CLN6 Gene Ceroid lipofuscinosis neuronal type 6 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 6

Test Details

The CLN6 gene is associated with a specific type of neurodegenerative disorder called ceroid lipofuscinosis neuronal type 6 (CLN6 NCL). This disorder is characterized by the abnormal accumulation of lipopigments (lipofuscin) in cells, leading to progressive neurological symptoms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CLN6 NCL, NGS genetic testing can be used to identify mutations or variants in the CLN6 gene that may be responsible for the disorder.

By identifying specific genetic changes in the CLN6 gene, NGS genetic testing can help confirm a diagnosis of CLN6 NCL in individuals with symptoms consistent with the disorder. It can also be used for carrier testing in individuals with a family history of CLN6 NCL to determine if they carry a mutation in the gene.

NGS genetic testing for CLN6 NCL can provide valuable information for patients and their families, including prognosis, genetic counseling, and potential treatment options. However, it is important to note that genetic testing results should always be interpreted by a healthcare professional with expertise in genetics.

Test Name CLN6 Gene Ceroid lipofuscinosis neuronal type 6 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CLN6 Gene Ceroid lipofuscinosis neuronal type 6 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 6
Test Details

The CLN6 gene is associated with a specific type of neurodegenerative disorder called ceroid lipofuscinosis neuronal type 6 (CLN6 NCL). This disorder is characterized by the abnormal accumulation of lipopigments (lipofuscin) in cells, leading to progressive neurological symptoms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CLN6 NCL, NGS genetic testing can be used to identify mutations or variants in the CLN6 gene that may be responsible for the disorder.

By identifying specific genetic changes in the CLN6 gene, NGS genetic testing can help confirm a diagnosis of CLN6 NCL in individuals with symptoms consistent with the disorder. It can also be used for carrier testing in individuals with a family history of CLN6 NCL to determine if they carry a mutation in the gene.

NGS genetic testing for CLN6 NCL can provide valuable information for patients and their families, including prognosis, genetic counseling, and potential treatment options. However, it is important to note that genetic testing results should always be interpreted by a healthcare professional with expertise in genetics.